FIRST MIDWEST BANK TRUST DIVISION - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 97 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2016. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.

Quarter-by-quarter ownership
FIRST MIDWEST BANK TRUST DIVISION ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q4 2021$404,000
+6.0%
13,816
-7.4%
0.05%
-3.7%
Q3 2021$381,000
-81.6%
14,916
-74.8%
0.05%
-80.6%
Q2 2021$2,072,000
+53.5%
59,163
+78.6%
0.28%
+50.0%
Q1 2021$1,350,000
-78.3%
33,125
-76.9%
0.19%
-79.4%
Q4 2020$6,222,000
+947.5%
143,656
+1232.6%
0.90%
+869.9%
Q3 2020$594,000
-16.0%
10,780
-3.7%
0.09%
-19.1%
Q2 2020$707,000
+23.0%
11,192
-0.6%
0.12%
+9.5%
Q1 2020$575,000
-39.0%
11,256
-5.1%
0.10%
-18.0%
Q4 2019$943,000
+17.9%
11,857
-28.1%
0.13%
+11.3%
Q3 2019$800,000
-53.2%
16,487
-49.3%
0.12%
-52.9%
Q2 2019$1,711,000
-62.9%
32,523
-62.7%
0.24%
-61.1%
Q1 2019$4,614,000
-41.5%
87,179
-54.7%
0.63%
-47.4%
Q4 2018$7,893,000
+174.2%
192,273
+153.8%
1.19%
+208.3%
Q3 2018$2,879,000
+432.2%
75,769
+533.0%
0.39%
+402.6%
Q2 2018$541,000
-14.3%
11,970
-25.4%
0.08%
-2.5%
Q4 2017$631,000
-22.2%
16,041
-71.4%
0.08%
-19.4%
Q4 2016$811,000
-48.9%
56,125
-18.5%
0.10%
-50.3%
Q3 2016$1,586,00068,8250.20%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q4 2016
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 356,270$24,262,00023.36%
Twin Securities, Inc. 376,669$25,651,00011.94%
Paradigm Biocapital Advisors LP 1,175,879$80,077,00010.68%
Chicago Capital Management, LLC 246,246$16,769,0009.12%
HARVEST MANAGEMENT LLC 141,500$9,636,0007.78%
Fernwood Investment Management, LLC 174,724$11,899,0005.02%
ArchPoint Investors 168,725$11,490,0004.69%
HAVENS ADVISORS LLC 46,000$3,133,0004.69%
Perceptive Advisors 2,322,247$158,145,0004.59%
Crabel Capital Management, LLC 112,680$7,674,0004.48%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders